InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,287.77
(
0.31%
)
Post# of 6072
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

onkelhubert

Send PM Follow Ignore
Followers 9
Posts 872
Boards Moderated 0
Alias Born 09/28/2011

onkelhubert

Re: umiak post# 4457

Tuesday, 08/21/2012 2:38:39 PM

Tuesday, August 21, 2012 2:38:39 PM

Post# of 6072
don't agree with you either. there are so many possibilties for off label use like every CHOP, CEOP, COMP etc. scheme.
many oncologists rather try an off label use if they see a possible advantage than sticking to their old schemes with worse odds.

therefore you need some well educated sales staff having some commercial experience in selling chemotherapeutics to get Marqibo out in the field and running. that's what big pharma has ...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up